Target intelligence / Profile preview

Tubulin folding cofactor A pseudogene 2 (TBCAP2)

Target
TBCAP2
Molecular classification
Other
01

Overview

Tubulin folding cofactor A pseudogene 2 (TBCAP2) is annotated as a *pseudogene*, not a protein-coding gene, and does not encode a functional protein. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they typically arise from gene duplication or retrotransposition events and lack protein-coding potential, regulatory elements, or both. There is no evidence to suggest TBCAP2 produces an active protein product or functions as a therapeutic target, enzyme, receptor, or cellular effector. Information regarding biological function, disease association, interacting drugs, or biomarker potential is lacking, as expected for pseudogenes. Any apparent association with cellular or disease processes is almost certainly coincidental or due to confusion with the protein-coding gene **TBCA (Tubulin folding cofactor A)**, which is involved in tubulin folding and microtubule assembly, but not its pseudogene forms[3].\n\nContextual clarification: \n- TBCA (Tubulin folding cofactor A), not TBCAP2, is a well-characterized protein-coding gene that acts as a chaperone in the folding of \u00df-tubulin during microtubule assembly, with known links to certain genetic disorders but is not a common direct therapeutic target[3][5].\n- TBCAP2, as a pseudogene, is not individually listed as a protein-coding target and has no established alias, functional classification, or drug interactions in authoritative databases.\n\nTherefore, **TBCAP2** is *not* a receptor, enzyme, transporter, or otherwise functional target, and information about biological or therapeutic relevance does not apply.

Beyond the preview

Go deeper on Tubulin folding cofactor A pseudogene 2 (TBCAP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tubulin folding cofactor A pseudogene 2 (TBCAP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call